A groundbreaking $50 million investment has been announced to combat the growing threat of antimicrobial resistance (AMR) in Nigeria and other low- and middle-income countries (LMICs). The initiative, launched by the Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome, aims to accelerate the discovery of new treatments for drug-resistant bacterial infections, which are … Continue reading $50M Investment Fuels Fight Against Antimicrobial Resistance In Low- and Middle-Income Countries